These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


4053 related items for PubMed ID: 6590919

  • 21. Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy.
    Novogrodsky A, Weisspapir M, Patya M, Meshorer A, Vanichkin A.
    Cancer Res; 1998 Jun 01; 58(11):2397-403. PubMed ID: 9622080
    [Abstract] [Full Text] [Related]

  • 22. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M, Viale M, Vannozzi MO, Zicca A, Cadoni A, Merlo F, Gogioso L.
    Toxicol Appl Pharmacol; 1996 Oct 01; 140(2):370-7. PubMed ID: 8887454
    [Abstract] [Full Text] [Related]

  • 23. Antitumor effect of 24R,25-dihydroxyvitamin D3.
    Maeda Y, Hirai T, Yamato H, Kobori N, Matsunaga K, Oguchi Y, Yoshimura M, Fujii T, Kobayashi Y, Saitoh K.
    In Vivo; 1988 Oct 01; 2(2):129-32. PubMed ID: 2979828
    [Abstract] [Full Text] [Related]

  • 24. [Effects of separate administration of low-dose CDDP on antitumor immune reactivity for treatment of malignant glioma].
    Nishihara T, Tanaka S, Murakami M, Hirakawa M, Nagashima T.
    Gan To Kagaku Ryoho; 1995 Aug 01; 22(9):1197-202. PubMed ID: 7661572
    [Abstract] [Full Text] [Related]

  • 25. [Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
    Sugimoto Y, Matsuo K, Takeda S, Yamada Y, Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Mar 01; 17(3 Pt 1):353-8. PubMed ID: 2138003
    [Abstract] [Full Text] [Related]

  • 26. L-histidinol: preclinical therapeutic studies in combination with antitumor agents and pharmacokinetic studies in mice.
    Zaharko D, Plowman J, Waud W, Dykes D, Malspeis L.
    Cancer Res; 1992 Jul 01; 52(13):3604-9. PubMed ID: 1617631
    [Abstract] [Full Text] [Related]

  • 27. [Influence of methylprednisolone on antitumor effect of cis-diamminedichloroplatinum (II)].
    Lee K, Kubota T, Sawamara M, Kadowaki K, Kawamura E, Egawa S, Ishibashi A.
    Gan To Kagaku Ryoho; 1984 Jul 01; 11(7):1444-9. PubMed ID: 6540069
    [Abstract] [Full Text] [Related]

  • 28. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
    Fulco RA, Vannozzi M, Collecchi P, Merlo F, Parodi B, Civalleri D, Esposito M.
    Anticancer Res; 1990 Jul 01; 10(6):1603-10. PubMed ID: 2285232
    [Abstract] [Full Text] [Related]

  • 29. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL, Su WY, Yen KC, Yang KC, Lin FH.
    Biomaterials; 2009 Jul 01; 30(20):3476-85. PubMed ID: 19345990
    [Abstract] [Full Text] [Related]

  • 30. Preclinical antitumor activity of bizelesin in mice.
    Carter CA, Waud WR, Li LH, DeKoning TF, McGovren JP, Plowman J.
    Clin Cancer Res; 1996 Jul 01; 2(7):1143-9. PubMed ID: 9816280
    [Abstract] [Full Text] [Related]

  • 31. Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer.
    Los G, Benbatoul K, Gately DP, Barton R, Christen R, Robbins KT, Vicario D, Kirmani S, Orloff LA, Weisman R, Howell SB.
    Clin Cancer Res; 1999 Jul 01; 5(7):1610-8. PubMed ID: 10430059
    [Abstract] [Full Text] [Related]

  • 32. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
    Khandalekar DD, Ganu UK, Gokhale SV.
    Indian J Physiol Pharmacol; 1989 Jul 01; 33(3):171-4. PubMed ID: 2592043
    [Abstract] [Full Text] [Related]

  • 33. Poly(gamma,L-glutamic acid)-cisplatin conjugate effectively inhibits human breast tumor xenografted in nude mice.
    Ye H, Jin L, Hu R, Yi Z, Li J, Wu Y, Xi X, Wu Z.
    Biomaterials; 2006 Dec 01; 27(35):5958-65. PubMed ID: 16949149
    [Abstract] [Full Text] [Related]

  • 34. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
    Breistøl K, Balzarini J, Sandvold ML, Myhren F, Martinsen M, De Clercq E, Fodstad O.
    Cancer Res; 1999 Jun 15; 59(12):2944-9. PubMed ID: 10383159
    [Abstract] [Full Text] [Related]

  • 35. Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
    Schiller JH, Bittner G.
    Clin Cancer Res; 1999 Dec 15; 5(12):4287-94. PubMed ID: 10632372
    [Abstract] [Full Text] [Related]

  • 36. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.
    Zagozdzon R, Stokłosa T, Gołab J, Giermasz A, Dabrowska A, Lasek W, Jakóbisiak M.
    Anticancer Res; 1997 Dec 15; 17(6D):4493-8. PubMed ID: 9494557
    [Abstract] [Full Text] [Related]

  • 37. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
    Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW.
    Clin Cancer Res; 1995 Aug 15; 1(8):847-57. PubMed ID: 9816054
    [Abstract] [Full Text] [Related]

  • 38. [Effect of cisplatin (CDDP) against peritonitis carcinomatosa in nude mice inoculated intraperitoneally with human gastric cancer].
    Takao S, Nomura H, Aikou T, Maenohara S, Saihara T, Kajisa T, Nishi M.
    Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1638-43. PubMed ID: 3896155
    [Abstract] [Full Text] [Related]

  • 39. [Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
    Fujita F, Fujita M, Sakamoto Y, Taguchi T.
    Gan To Kagaku Ryoho; 1993 Feb 15; 20(2):215-21. PubMed ID: 8382036
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 203.